Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Global Estimates on the Number of People Blind or Visually Impaired by Glaucoma: A Meta-Analysis From 2000 to 2020 Publisher Pubmed

Summary: Study finds glaucoma causes 3.61M blind globally, with Sub-Saharan Africa hit hardest. #Glaucoma #VisionLoss

Bourne RRA284 ; Jonas JB1, 63, 64, 227 ; Friedman D2 ; Nangia V3 ; Bron A4, 68, 69 ; Tapply I5, 70 ; Fernandes AG6, 7, 71 ; Cicinelli MV8, 9, 72 ; Arrigo A10 ; Leveziel N11, 12, 73, 74 ; Resnikoff S13, 14, 77 ; Taylor HR15 ; Sedighi T284 ; Bikbov MM16 Show All Authors
Authors
  1. Bourne RRA284
  2. Jonas JB1, 63, 64, 227
  3. Friedman D2
  4. Nangia V3
  5. Bron A4, 68, 69
  6. Tapply I5, 70
  7. Fernandes AG6, 7, 71
  8. Cicinelli MV8, 9, 72
  9. Arrigo A10
  10. Leveziel N11, 12, 73, 74
  11. Resnikoff S13, 14, 77
  12. Taylor HR15
  13. Sedighi T284
  14. Bikbov MM16
  15. Braithwaite T17, 18, 126, 127
  16. Cheng CY19, 20
  17. Congdon N21, 22, 23
  18. Del Monte MA24, 25
  19. Ehrlich JR26, 27, 150, 151
  20. Fricke T28, 29, 30
  21. Furtado JM31, 164
  22. Gazzard G32
  23. George R34
  24. Hartnett ME35
  25. Kahloun R36, 181
  26. Kempen JH37, 38, 39, 40
  27. Khairallah M41
  28. Khanna RC42, 43, 44, 45
  29. Kim JE46
  30. Lansingh VC47, 48, 49
  31. Leasher J50, 194
  32. Naidoo KS51, 52
  33. Nowak M53
  34. Pesudovs K54
  35. Peto T56
  36. Ramulu P57
  37. Topouzis F58
  38. Tsilimbaris M59
  39. Wang YX60
  40. Wang N61
  41. Flaxman S62, 283
  42. Casson RJ65
  43. Friedman DS66
  44. Nangia V3
  45. Briant PS75
  46. Vos T75, 76
  47. Abate YH78
  48. Abate MD79
  49. Dolatabadi ZA80
  50. Abdollahi M81
  51. Aboagye RG82
  52. Abugharbieh E83
  53. Aburuz S84, 85
  54. Adnani QES86
  55. Aghamiri S87
  56. Ahinkorah BO88
  57. Ahmad D89, 90
  58. Ahmadieh H91, 92
  59. Ahmadzadeh H93
  60. Ahmed A94, 95
  61. Alfaar AS96, 97
  62. Alinia C98
  63. Almidani L99, 100
  64. Amu H101
  65. Androudi S102
  66. Anil A103, 104
  67. Arabloo J105
  68. Areda D106, 107
  69. Ashraf T108
  70. Bagherieh S109
  71. Baltatu OC110
  72. Baran MF111
  73. Barrow A112, 113
  74. Bashiri A115
  75. Bayileyegn NS116
  76. Bazvand F117
  77. Berhie AY118
  78. Bhatti JS119
  79. Bikbov M120
  80. Birck MG121, 122
  81. Bitra VR123
  82. Bozic MM124, 125
  83. Burkart K75, 76
  84. Bustanji Y129, 130
  85. Butt ZA131, 132
  86. Cenderadewi M133, 134
  87. Chattu VK135, 136
  88. Coberly K75
  89. Dadras O137, 138
  90. Dai X75, 76
  91. Dascalu AM139, 140
  92. Dastiridou A141, 142
  93. Devanbu VGC143
  94. Dhimal M144
  95. Diaz D145, 146
  96. Do THP147
  97. Do TC148
  98. Dziedzic AM149
  99. Ekholuenetale M152, 153
  100. Elhadi M154
  101. Emamian MH155
  102. Emamverdi M156
  103. Farrokhpour H157, 158
  104. Fetensa G159
  105. Fischer F160
  106. Forouhari A161, 162
  107. Fowobaje KR152, 163
  108. Gandhi AP165
  109. Gebregergis MWW166
  110. Goulart BNG167
  111. Gudeta MD168
  112. Gupta S169
  113. Gupta VK170
  114. Gupta VB171
  115. Heidari G172
  116. Hong SH173, 174
  117. Huynh HH175
  118. Ibitoye SE176
  119. Ilic IM124
  120. Immurana M177
  121. Jayapal SK178
  122. Joseph N179
  123. Joshua CE180
  124. Kandel H182, 183
  125. Karaye IM184, 185
  126. Kasraei H186, 187
  127. Kebebew GM159
  128. Khalafalla MT188
  129. Khanal S189
  130. Khatib MN190
  131. Krishan K191
  132. Lahariya C192, 193
  133. Lim SS75, 76
  134. Marzo RR195, 196
  135. Maugeri A197
  136. Meng Y198
  137. Mestrovic T75, 199
  138. Mishra M200
  139. Mohamed NS201, 202
  140. Mojiriforushani H203
  141. Mokdad AH75, 76
  142. Momenimoghaddam H204, 205
  143. Montazeri F206, 207
  144. Mulita A208
  145. Murray CJL75, 76
  146. Foodani MN80
  147. Naik GR209, 210
  148. Natto ZS211, 212
  149. Nayak BP213
  150. Negaresh M214, 215
  151. Negash H216
  152. Nguyen DH217, 218
  153. Oancea B219
  154. Olagunju AT220, 221
  155. Olatubi MI222
  156. Osman WMS223
  157. Osuagwu UL224, 225
  158. Padubidri JR226
  159. Pardhan S284
  160. Park S228
  161. Patel J229, 230
  162. Perianayagam A231
  163. Pham HT232
  164. Prates EJS233
  165. Qattea I234
  166. Rahim F235, 236
  167. Rahman M237
  168. Rapaka D238
  169. Rawaf S239, 240
  170. Rezaei N206
  171. Roy P241
  172. Saddik B242
  173. Saeed U243, 244
  174. Safi SZ245, 246
  175. Safi S247, 248
  176. Sakshaug JW249, 250
  177. Saleh MA251, 252
  178. Samuel VP253
  179. Samy AM254, 255
  180. Saravanan A256, 257
  181. Seylani A258
  182. Shaikh MA259
  183. Shamim MA103
  184. Shannawaz M260
  185. Shashamo BB261
  186. Shayan M248, 262
  187. Shittu A263
  188. Siddig EE264, 265
  189. Singh JA266, 267
  190. Solomon Y268
  191. Sousa RARC269
  192. Tabatabaei SM270, 271
  193. Tabish M272
  194. Ticoalu JHV273
  195. Toma TM274
  196. Tsatsakis A275
  197. Tsegay GM276
  198. Valizadeh R277
  199. Viskadourou M278
  200. Wassie GT279
  201. Wickramasinghe ND280
  202. Yon DK281
  203. You Y182, 282
  204. Steinmetz JD75

Source: Eye (Basingstoke) Published:2024


Abstract

Objectives: To estimate global and regional trends from 2000 to 2020 of the number of persons visually impaired by glaucoma and their proportion of the total number of vision-impaired individuals. Methods: A systematic review and meta-analysis of published population studies and grey literature from 2000 to 2020 was carried out to estimate global and regional trends in number of people with vision loss due to glaucoma. Moderate or severe vision loss (MSVI) was defined as visual acuity of 6/60 or better but <6/18 (moderate) and visual acuity of 3/60 or better but <6/60 (severe vision loss). Blindness was defined as presenting visual acuity <3/60. Results: Globally, in 2020, 3.61 million people were blind and nearly 4.14 million were visually impaired by glaucoma. Glaucoma accounted for 8.39% (95% uncertainty intervals [UIs]: 6.54, 10.29) of all blindness and 1.41% (95% UI: 1.10, 1.75) of all MSVI. Regionally, the highest proportion of blindness relating to glaucoma was found in high-income countries (26.12% [95% UI: 20.72, 32.09]), while the region with the highest age-standardized prevalence of glaucoma-related blindness and MSVI was Sub-Saharan Africa. Between 2000 and 2020, global age-standardized prevalence of glaucoma-related blindness among adults ≥50 years decreased by 26.06% among males (95% UI: 25.87, 26.24), and by 21.75% among females (95% UI: 21.54, 21.96), while MSVI due to glaucoma increased by 3.7% among males (95% UI: 3.42, 3.98), and by 7.3% in females (95% UI: 7.01, 7.59). Conclusions: Within the last two decades, glaucoma has remained a major cause of blindness globally and regionally. © The Author(s) 2024.
Other Related Docs
15. Comparison of Applanation Tonometry With and Without Fluorescein, Journal of Isfahan Medical School (2011)
18. Effects of Propranolol in Patients With Central Serous Chorioretinopathy, Journal of Research in Medical Sciences (2008)
20. Convergence Insufficiency in the Geriatric Population, Optometry and Vision Science (2021)